Corporation under Due Diligence- update
Spectros Corporation presentation last month a few members, Jacob Dayan,
Marcel Cohen, Omy Shani, Israel Beinglass and Edith Ong led the due
diligence in the company. Last week more members joined the DD team
to look deeper into 4 segments as follow:
Gary Benton (lawyer from Coudert Brothers) and Yoram Arbel will join
Israel Beinglass and Marcel Cohen to look into the term sheet
2. Lawrence Edelman (patent lawyer) will join Edith Ong to examine the
3. Daniel Platzker will join Edith Ong to check management reference.
4. Dr Sokoloff will join Omy Shai to check the Technology and the market.
Eran Geller is also available to share his experience on Spectros product.
raised a bridge loan from Silicom Ventures members. Eli Sternheim joined
the Board of Directors.
Materials Inc. received a term sheet of $8.5 million in Series
B financing. IMI continues to make progress with customers in Asia,
Europe and the US and introduced its "ultra-clean" product.
about Rafi Holtzman the CEO of Luidia in the IVC March issue Col. 4
launches AC-4G-D to address computer industry's growing CPU heat crisis
and PC noise concerns. The former CEO Ronen Meir was replaced by David
Technologies Global Specialty Chemicals Manufacturer Sartomer
Deploys Vsecure's NetProtect(TM) Enterprise Intrusion Prevention Appliance
for Network Security.
Summer Break Party
pencil down May 22nd @ 8PM for Silicom Ventures first summer break dance
party. The party is for Silicom Ventures members and spouses and will
take place in Los Altos Hills. Stay tunes for further details.
this column we will follow up on startups that presented in the past
to Silicom Ventures forum but didn't generated investments.
Technologies a developer of Book Scanner system presented
on June 11, 2002. Please click
here to read recent article.
invented universal secure remote access, digital key solution. Presented
on January 14, 2003. Click
here to read their first article.
View Pharmaceuticals from the Biopharmaceutical
drug delivery industry presented on September 3, 2002 have some good
news:Savient Pharmaceuticals, Inc. (formerly Bio-Technology General
Corp.), the licensee of the PEG-uricase invented and patented by scientists
from Mountain View Pharmaceuticals, Inc., and Duke University, has
begun a multi-center, Phase II clinical trial. The attached press
release from Savient provides more details about this drug for treatment
of intractable gout, for which MVP has registered the trademark Puricase(R).
If you can't
view this HTML email please visit this link http://www.silicomventures.com/newsletter_3_04/index.htm
is welcome. For articles and any information that might interest the group
to be posted on the next newsletter, Please contact: firstname.lastname@example.org.
Ventures is not a brokers nor investment advisors and do not provide
investment advice, and this newsletter should not be relied on as such
nor is it a substitute for investment advice. The information provided
in this newsletter based from sources believed to be reliable and in
good faith , it is not guaranteed either as to accuracy or completeness,
and independent verification should be sought before making any decisions.
Silicom Ventures Events
Khosla General Partner of Kleiner Perkins Caufield & Byers
Manber, VP and Chief Algorithms Officer, Amazon.com
G. Coleman,Chief Strategist, Netscape Division of AOL iPlane
Kristofer S.J. Pistert will speak about "Smart